The use of colesevelam hydrochloride in the treatment of dyslipidemia: a review

This publication has 30 references indexed in Scilit:

• Heart Disease and Stroke Statistics—2007 Update
  Circulation, 2007
• Results of the glucose-lowering effect of WelChol study (GLOWS): A randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes
  Clinical Therapeutics, 2007
• Lipid-lowering effects of colesevelam HCl in combination with ezetimibe
  Current Medical Research and Opinion, 2006
• Effects of Colesevelam Hydrochloride (WelChol) on Biomarkers of Inflammation in Patients With Mild Hypercholesterolemia
  The American Journal of Cardiology, 2006
• Effects of Colesevelam Hydrochloride on Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein When Added to Statins in Patients With Hypercholesterolemia
  The American Journal of Cardiology, 2006
• Clinical Utility of Bile Acid Sequestrants in the Treatment of Dyslipidemia: A Scientific Review
  Southern Medical Journal, 2006
• Safety and efficacy of colesevelam hydrochloride in combination with fenofibrate for the treatment of mixed hyperlipidemia
  Current Medical Research and Opinion, 2005
• The Enzymes, Regulation, and Genetics of Bile Acid Synthesis
  Annual Review of Biochemistry, 2003
• Nuclear Receptor Regulation of Genes Involved in Bile Acid Metabolism
  Critical Reviews™ in Eukaryotic Gene Expression, 2002
• Colesevelam hydrochloride: a non-absorbed, polymeric cholesterol-lowering agent
  Expert Opinion on Investigational Drugs, 2000